VELKOMMEN TIL RIKSHOSPITALETS POWERPOINTMAL

1
Open discussions constitution and prospects

• 43 participants / 16 countries US 11 EU 4
  non-EU
• Aims - international
• Grant opportunities
• Driven by projects
• Clinical trials (recruitment/design/endpoints)
• Genetic studies
• Cholangiocarcinoma
• Animal models
• Immunology/pathogenesis
• Transplantation
• Membership inclusive vs. exclusive
• Regular meetings (AASLD/EASL) short/lunch/fixed
  date
• Concluding session at end of meeting
• Steering group
• Secretariat
• Website
• Plan for circulation of minutes